Key terms
About GDRX
GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The firm offers consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. The company was founded by Trevor Bezdek and Douglas Joseph Hirsch in September 2011 and is headquartered in Santa Monica, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest GDRX news
Apr 12
6:40am ET
Analysts Are Bullish on These Healthcare Stocks: GoodRx Holdings (GDRX), Arcutis Biotherapeutics (ARQT)
Apr 05
5:07pm ET
GoodRx files to sell 99.98M shares of Class A common stock for holders
Apr 04
9:20am ET
‘Time to Hit Buy,’ Says Wells Fargo About These 2 Stocks
Apr 02
7:30am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Biomea Fusion (BMEA) and GoodRx Holdings (GDRX)
Mar 25
9:44am ET
Tesla downgraded, Disney upgraded: Wall Street’s top analyst calls
Mar 25
5:29am ET
Wells Fargo upgrades GoodRx on improved revenue visibility
Mar 25
5:16am ET
GoodRx upgraded to Overweight from Equal Weight at Wells Fargo
Mar 14
8:42am ET
GoodRx Adjusts CEO Contract and Announces Board Changes
Mar 08
7:27am ET
RBC Capital Keeps Their Hold Rating on GoodRx Holdings (GDRX)
Mar 07
5:32pm ET
GoodRx Reaffirms Financial Leadership with CFO’s Renewed Contract
Mar 01
9:46am ET
GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls
Mar 01
8:08am ET
GoodRx price target raised to $10 from $9 at Guggenheim
Mar 01
7:43am ET
GoodRx price target raised to $7.50 from $6 at Wells Fargo
Mar 01
7:36am ET
Truist Financial Sticks to Their Hold Rating for GoodRx Holdings (GDRX)
Mar 01
7:28am ET
RBC Capital Sticks to Their Hold Rating for GoodRx Holdings (GDRX)
Mar 01
7:20am ET
GoodRx price target raised to $8 from $5 at UBS
Mar 01
7:18am ET
GoodRx price target raised to $14 from $12 at TD Cowen
Mar 01
6:17am ET
GoodRx Holdings: A Cautious Hold Amidst Positive Profit Outlook and Strategic Initiatives
Mar 01
6:10am ET
GoodRx price target raised to $10 from $8 at Citi
Mar 01
5:35am ET
GoodRx price target raised to $9 from $8 at Barclays
Mar 01
5:01am ET
GoodRx upgraded to Overweight from Neutral at JPMorgan
Mar 01
4:59am ET
Hold Rating on GoodRx Holdings Amid Growth and Strategy Concerns
Mar 01
4:31am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Argenx Se (ARGX), GoodRx Holdings (GDRX) and Annexon Biosciences (ANNX)
Mar 01
2:56am ET
Barclays Keeps Their Buy Rating on GoodRx Holdings (GDRX)
Feb 29
6:15pm ET
GoodRx Holdings: Balancing Strengths and Concerns with a Hold Rating
Feb 29
4:50pm ET
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX) and COMPASS Pathways (CMPS)
Feb 29
8:55am ET
GoodRx Holdings Sell Rating: Uncertainty in Growth Reliance and Questionable Capital Allocation Strategy
Feb 29
6:11am ET
GoodRx sees FY24 revenue ~$800M, consensus $790.53M
Feb 29
6:10am ET
GoodRx sees Q1 revenue $195M-$198M, consensus $192.91M
Feb 29
6:10am ET
GoodRx reports Q4 adjusted EPS 8c, consensus 7c
Feb 27
11:38pm ET
GoodRx Holdings: A Strong Buy on Robust Growth and Margin Expansion Prospects
No recent press releases are available for GDRX
GDRX Financials
Key terms
Ad Feedback
GDRX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
GDRX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
